Media Summary: On today's episode, Stacey Bruzzese welcomes Ivan Soto, Director Manufacturing Validation for Emergent BioSolutions. An exploration of the essential components of Phillip D. Kronstein from CDER's Good Clinical Practice Assessment Branch provides a case study when a sponsor submitted an ...
Data Integrity Audit Trail Review Requirement - Detailed Analysis & Overview
On today's episode, Stacey Bruzzese welcomes Ivan Soto, Director Manufacturing Validation for Emergent BioSolutions. An exploration of the essential components of Phillip D. Kronstein from CDER's Good Clinical Practice Assessment Branch provides a case study when a sponsor submitted an ... On today's episode, Stacey Bruzzese welcomes Matthew LaPierre to talk about MHRA's Operations Manager GLPMA & Laboratories Group Stephen Vinter discusses ICH E6 (R2) and how well designed and ... This webinar from CluePoints, GSK, and Pfizer highlights how global pharma leaders use Time-Based Testing (TBT) in ...
This is part - 1 of the video. This video will help to understand about 'what is mean by Novartis' Christian Scheidl discusses the role of This episode gives analysts the database literacy needed to investigate incidents, validate suspicious activity, and interpret In this video, we break down Chromatography DI (Reprocessing / Integration) in a practical way for pharmaceutical, biotech, and ...